Dr. Jing Zhuang 庄競
Chief Physician
Department of General Surgery, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastric cardia cancer, colorectal cancer, and urological tumors.
Dr. Zhuang is Chief Physician and Deputy Director of General Surgery at Henan Cancer Hospital. A visiting scholar at Loyola University Hospital (Chicago) and Creighton University (Omaha), Dr. Zhuang specializes in open and laparoscopic surgery for colorectal and gastric cardia cancers. Dr. Zhuang leads provincial research projects and has published over 20 papers.
Professional roles
- Chair, Colorectal Cancer Professional Committee, Henan Anti-Cancer Association
- Vice Chair, Parenteral and Enteral Nutrition Branch, Henan Medical Association
- Deputy Leader, Gastrointestinal Stromal Tumor Group, Henan Anti-Cancer Association
- Member, Editorial Board, Journal of Clinical Surgery
Name order: in Chinese the family name comes first (Zhuang Jing). Papers usually list the name as Jing Zhuang or Zhuang J.
Selected publications
13 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Biochem Cell Biol, 2024 (senior author): Corrigendum to "Graphene oxide leads to mitochondrial-dependent apoptosis by activating ROS-p53-mPTP pathway in intestinal cells" [Int. J. Biochem. Cell Biol. 146 (2022) 106206]. PubMed 39054165
- Asian J Surg, 2023 (senior author): A case report of small bowel to bladder fistula after rectal cancer operation. PubMed 36581544
- Int J Biochem Cell Biol, 2022 (senior author): Graphene oxide leads to mitochondrial-dependent apoptosis by activating ROS-p53-mPTP pathway in intestinal cells. PubMed 35398141
- Front Genet, 2020 (senior author): Long Non-coding RNA LINC00115 Contributes to the Progression of Colorectal Cancer by Targeting miR-489-3p via the PI3K/AKT/mTOR Pathway. PubMed 33193658
- Pak J Pharm Sci, 2015 (senior author): Clinical curative effect of oxaliplatin combined with flurouracil in the treatment of gastrointestinal tumor. PubMed 26051738
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers; we checked the papers' affiliations and topics against this doctor's department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion